Joinn Laboratories(China)Co.Ltd Management

Management criteria checks 2/4

Joinn Laboratories(China)Co.Ltd's CEO is Dapeng Gao, appointed in Mar 2013, has a tenure of 11.17 years. directly owns 0.039% of the company’s shares, worth CN¥4.34M. The average tenure of the management team and the board of directors is 11.3 years and 5.3 years respectively.

Key information

Dapeng Gao

Chief executive officer

CN¥2.2m

Total compensation

CEO salary percentage	n/a
CEO tenure	11.2yrs
CEO ownership	0.04%
Management average tenure	11.3yrs
Board average tenure	5.3yrs

Recent management updates

Recent updates

Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially

Apr 08

There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings

Apr 04

CEO Compensation Analysis

How has Dapeng Gao's remuneration changed compared to Joinn Laboratories(China)Co.Ltd's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	-CN¥63m
Dec 31 2023	n/a	n/a	CN¥397m
Sep 30 2023	n/a	n/a	CN¥770m
Jun 30 2023	n/a	n/a	CN¥794m
Mar 31 2023	n/a	n/a	CN¥1b
Dec 31 2022	CN¥2m	n/a	CN¥1b
Sep 30 2022	n/a	n/a	CN¥941m
Jun 30 2022	n/a	n/a	CN¥775m
Mar 31 2022	n/a	n/a	CN¥589m
Dec 31 2021	CN¥2m	CN¥644k	CN¥557m
Sep 30 2021	n/a	n/a	CN¥419m
Jun 30 2021	n/a	n/a	CN¥379m
Mar 31 2021	n/a	n/a	CN¥389m
Dec 31 2020	CN¥2m	CN¥573k	CN¥315m
Sep 30 2020	n/a	n/a	CN¥253m
Jun 30 2020	n/a	n/a	CN¥237m
Mar 31 2020	n/a	n/a	CN¥194m
Dec 31 2019	CN¥1m	CN¥483k	CN¥187m

Compensation vs Market: Dapeng's total compensation ($USD304.89K) is above average for companies of similar size in the CN market ($USD173.62K).

Compensation vs Earnings: Dapeng's compensation has increased whilst the company is unprofitable.

CEO

Dapeng Gao (41 yo)

11.2yrs

Tenure

CN¥2,207,700

Compensation

Mr. Dapeng Gao is the Executive Director of Joinn Laboratories (China) Co.,Ltd. since August 2020 and has been its General Manager since January 28, 2019 and Joint Secretary since January 2019 and August 2...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Yuxia Feng	Founder & Chairman	11.4yrs	CN¥3.24m	22.38% CN¥ 2.5b
Dapeng Gao	GM, Secretary to the Board	11.2yrs	CN¥2.21m	0.039% CN¥ 4.3m
Conglin Zuo	Co-Founder & Vice Chairman	11.4yrs	CN¥2.48m	1.89% CN¥ 212.0m
Aishui Yu	Chief Financial Officer	4.8yrs	CN¥1.61m	0.0046% CN¥ 513.3k
Jingliang Gu	Vice GM & Head of Sales Department	13.3yrs	CN¥2.21m	0.036% CN¥ 4.1m
Yunxia Sun	Vice GM & Executive Director	11.4yrs	CN¥2.50m	0.36% CN¥ 40.6m
Dalin Yao	Senior Vice GM	12.3yrs	CN¥1.42m	0.010% CN¥ 1.2m
Ka Lun Cheung	Joint Company Secretary	2.1yrs	no data	no data

11.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 603127's management team is seasoned and experienced (11.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Yuxia Feng	Founder & Chairman	11.4yrs	CN¥3.24m	22.38% CN¥ 2.5b
Dapeng Gao	GM, Secretary to the Board	10.7yrs	CN¥2.21m	0.039% CN¥ 4.3m
Conglin Zuo	Co-Founder & Vice Chairman	11.4yrs	CN¥2.48m	1.89% CN¥ 212.0m
Yunxia Sun	Vice GM & Executive Director	5.3yrs	CN¥2.50m	0.36% CN¥ 40.6m
Dalin Yao	Senior Vice GM	5.3yrs	CN¥1.42m	0.010% CN¥ 1.2m
Ye Li	Supervisor	11.4yrs	no data	0.014% CN¥ 1.5m
Mingcheng Sun	Independent Non-Executive Director	5.3yrs	CN¥150.00k	no data
Yonggong Zhai	Independent Non-Executive Director	5.3yrs	CN¥150.00k	no data
Xiaojie Ou	Independent Non-Executive Director	5.3yrs	CN¥150.00k	no data
Fan Zhang	Independent Non-Executive Director	3.3yrs	CN¥154.70k	no data
Yingjun He	Chairman of the Supervisory Board	1.5yrs	no data	no data

5.3yrs

Average Tenure

50yo

Average Age

Experienced Board: 603127's board of directors are considered experienced (5.3 years average tenure).

Joinn Laboratories(China)Co.Ltd Management

Management criteria checks 2/4

Key information

Recent management updates

GM, Secretary to the Board recently sold CN¥2.5m worth of stock

Co-Founder & Vice Chairman recently sold CN¥6.2m worth of stock

Vice GM & Executive Director recently sold CN¥6.9m worth of stock

Co-Founder & Vice Chairman recently sold CN¥12m worth of stock

Co-Founder & Vice Chairman recently sold CN¥12m worth of stock

Co-Founder & Vice Chairman recently sold CN¥8.9m worth of stock

Recent updates

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially

There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings

Consensus revenue estimates fall by 19%

Joinn Laboratories(China)Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Consensus EPS estimates fall by 19%

Price target decreased by 8.6% to CN¥22.33

Investor sentiment improves as stock rises 19%

Now 23% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Now 23% undervalued after recent price drop

Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2023

Price target decreased by 7.2% to CN¥25.92

Price target decreased by 7.3% to CN¥28.66

Now 20% undervalued after recent price drop

Joinn Laboratories(China)Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

GM, Secretary to the Board recently sold CN¥2.5m worth of stock

Consensus EPS estimates fall by 27%

Now 20% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates increase by 700%

New minor risk - Share price stability

Co-Founder & Vice Chairman recently sold CN¥6.2m worth of stock

Vice GM & Executive Director recently sold CN¥6.9m worth of stock

Consensus EPS estimates increase by 24%

Consensus EPS estimates fall by 10%

Price target decreased by 11% to CN¥33.30

Second quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 13% to CN¥37.55

Now 25% undervalued after recent price drop

Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023

Price target decreased by 8.7% to CN¥57.93

Co-Founder & Vice Chairman recently sold CN¥12m worth of stock

Co-Founder & Vice Chairman recently sold CN¥12m worth of stock

Co-Founder & Vice Chairman recently sold CN¥8.9m worth of stock

Joinn Laboratories (China) Co.,Ltd. Declares Final Dividend for the Year Ended December 31, 2022, Payable on 20 July 2023

Joinn Laboratories(China)Co.,Ltd., Annual General Meeting, Jun 09, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 7.4% to CN¥70.19

Price target increased by 7.4% to CN¥76.57

Insider recently sold CN¥56m worth of stock

JOINN Laboratories (China) Co., Ltd. Provides Revenue Guidance for the Period January 1, 2022 to December 31, 2022

Insider recently sold CN¥57m worth of stock

Co-Founder & Vice Chairman recently sold CN¥31m worth of stock

Insider recently sold CN¥30m worth of stock

Co-Founder & Vice Chairman recently sold CN¥65m worth of stock

Price target decreased to CN¥71.30

Less than half of directors are independent

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 21% undervalued after recent price drop

Co-Founder & Vice Chairman recently sold CN¥180m worth of stock

Price target increased to CN¥86.02

Insider recently sold CN¥60m worth of stock

Now 21% undervalued after recent price drop

Price target decreased to CN¥74.80

Second quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.11 in 2Q 2021)

Joinn Laboratories(China)Co.,Ltd. SHS (China) to Be Deleted from OTC Equity

Joinn Laboratories(China)Co.,Ltd. to Report Q2, 2022 Results on Aug 30, 2022

Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Period from 1 January 2022 to 30 June 2022

Senior Vice GM recently sold CN¥233k worth of stock

Joinn Laboratories(China)Co.,Ltd. Approves Final Dividend in Cash for the Year Ended December 31, 2021, Payable on 23 August 2022

Vice GM & Executive Director recently sold CN¥4.6m worth of stock

Founder & Chairman recently sold CN¥51m worth of stock

Investor sentiment improved over the past week

Joinn Laboratories (China) Co.,Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021, Payable on 23 August 2022

Founder & Chairman recently sold CN¥36m worth of stock

Price target increased to CN¥130

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind